Pilot of Mailing Buprenorphine

Part of paid clinical trials in Charleston, South Carolina.

Sponsor
Medical University of South Carolina
Study ID
NCT07421102
Phase
EARLY_PHASE1
Status
Recruiting
Apply to this trial

Conditions

  • Opioid Use Disorder

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • strategy of mailing buprenorphine — OTHER
    This study examines the feasibility and preliminary effectiveness of mailing buprenorphine to overcome barriers such as transportation to obtaining buprenorphine from a pharmacy.

Study Details

This pilot study evaluates the feasibility, acceptability, and preliminary effectiveness of mailing buprenorphine to individuals with opioid use disorder (OUD) following medical hospitalization. The intervention aims to improve retention in treatment by overcoming barriers such as transportation and pharmacy access.

Key Dates

Start date
Apr 30, 2026
Status verified
Apr 2026
Primary completion
Jan 31, 2027
Completion
Mar 31, 2027

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Other: Mailed Medications
    There is no comparison arm. This pilot study evaluates the feasibility of mailing medications to patients.

Primary Outcome Measure

Feasibility (successful receipt) [ Time Frame: From enrollment to the end of the study at 6 months ]

Locations (2)

FacilityCityStateZIPSite coordinators
Medical University of South CarolinaCharlestonSouth Carolina29425
Allison Smith, MD
[email protected]
843-792-2100
Allison Smith, MD (PRINCIPAL_INVESTIGATOR)
Medical University of South CarolinaCharlestonSouth Carolina29425
Primary Investigator, MD
[email protected]
843-792-0686
Research Coordinator, BS
[email protected]
Allison Smith, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Charleston, SC

By research site
Medical University of South Carolina· Charleston, SC

Related Studies